4.8 Review

Mechanisms of gastrointestinal allergic disorders

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 129, Issue 4, Pages 1419-1430

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI124604

Keywords

-

Funding

  1. NIH [R01 AI124355, R37 A1045898, U19 AI070235]
  2. Campaign Urging Research for Eosinophilic Disease (CURED) Foundation
  3. Sunshine Charitable Foundation
  4. Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) as part of the Rare Diseases Clinical Research Network, an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS) - National I [U54 AI117804]
  5. Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) as part of the Rare Diseases Clinical Research Network, an initiative of the Office National Institute of Diabetes and Digestive and Kidney Diseasesof Rare Diseases Research, National [U54 AI117804]
  6. Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) as part of the Rare Diseases Clinical Research Network, an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS) - NCATS [U54 AI117804]
  7. American Partnership for Eosinophilic Disorders
  8. Campaign Urging Research for Eosinophilic Disease (CURED)
  9. Eosinophilic Family Coalition

Ask authors/readers for more resources

Gastrointestinal (GI) allergic disease is an umbrella term used to describe a variety of adverse, food antigen-driven, immunemediated diseases. Although these diseases vary mechanistically, common elements include a breakdown of immunologic tolerance, a biased type 2 immune response, and an impaired mucosal barrier. These pathways are influenced by diverse factors such as diet, infections, exposure to antibiotics and chemicals, GI microbiome composition, and genetic and epigenetic elements. Early childhood has emerged as a critical period when these factors have a dramatic impact on shaping the immune system and therefore triggering or protecting against the onset of GI allergic diseases. In this Review, we will discuss the latest findings on the molecular and cellular mechanisms that govern GI allergic diseases and how these findings have set the stage for emerging preventative and treatment strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available